Raymond James Starts Insmed (INSM) at Outperform, Citing Limited Competition
Summary
On April 9, 2026, Raymond James initiated coverage of Insmed Incorporated (NASDAQ:INSM) with an Outperform rating. The firm’s analyst set a price target of $2...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.